Roche to buy gene therapy specialist Spark in $4.3 billion deal
Roche already sells Hemlibra, a drug against haemophilia A that helps stop bleeding in patients with the life-threatening genetic disorder that prevents their blood from clotting properly.
No comments:
Post a Comment